Vouliez-vous dire
clinical materials

Résultats de la recherche - 81 results

Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.

One of the candidate antiviral medicines tested was ivermectin. Although several health authorities warned the public against the use of this medicine outside clinical trials, the drug was widely used ...

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.

Publication Type: Peer reviewed scientific article Authors: Onnockx, Sheela; Aline Baldo; Katia Pauwels Source: Vaccines (Basel), Volume 11, Issue 9 (2023) Keywords: biosafety cancer Clinical trials ...

Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study.

early treatment. FUNDING: German Federal Ministry of Education and Research and the European & Developing Countries Clinical Trials Partnership. TRANSLATION: For the Swahili translation of the abstract see ...

What do we request for production and quality control of CHIM strains.Should it be GMP or is adherence to GMP acceptable?

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: Ethical Approval for CHIM Clinical Trial Protocols, IABS, Brussels, Belgium (2023) Service:  Qualité ...

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.

the following six months. The trial is registered on ClinicalTrials.gov (NCT04527614). FINDINGS: All included residents (n = 85) and staff members (n = 88) were SARS-CoV-2 infection naïve at third dose ...

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

currently in use in most low and middle-income countries, warranting larger immunogenicity and effectiveness trials. Service:  Maladies infectieuses humaines Infectieziekten mens Infectious diseases in humans ...

Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.

Publication Type: Peer reviewed scientific article Authors: Hannah M Garcia Garrido; Bridget van Put; Sanne Terryn; Cornelis A de Pijper; Cornelis Stijnis; Geert R D'Haens; Phyllis I Spuls; Marleen G Van de Sande; Steven Van Gucht; Martin P Grobusch; ...

From b to y ions, a decade of experience with peptide and protein analysis

clinical trials. The Belgian Federal Agency for Medicines and Health Products (FAMHP) and customs are striving, together with their global counterparts, to curtail the trafficking and distributions of these ...

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.

Mikstacki; José-Artur Paiva; Cecilia Pereyra; Jordi Rello; Jean-Francois Timsit; Vogelaers, Dirk; Blot, Stijn; Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive ...

QR code

QR code for this page URL